Investment
Features
FeesSafety
Academy
More
Pluang+

Wells Fargo upgrades Cleveland-Cliffs to Overweight with $14 target amid rising steel prices.

Analyst Insights
06 Oct 2026
Blockonomi
View Source
Bullish
Wells Fargo upgrades Cleveland-Cliffs to Overweight with $14 target amid rising steel prices.

Wells Fargo raised Cleveland-Cliffs' rating to Overweight and increased its price target from $12 to $14, citing expectations that the company's EBITDA in late 2026 and 2027 will exceed current estimates. Steel prices have surged from $900 to $1,300 per ton this year, boosting profit potential. Despite this, only 25% of analysts currently recommend buying CLF shares, though this is improving. The company faces future competition from a new large steel plant in Iowa but remains valued on near-term earnings prospects. Quarterly results are due in 13 days, with cost pressures noted as a concern.

The story on Cleveland-Cliffs and steel price surges is presented here alongside Pluang's market data for context. As of Oct 07, 2026 00:03 WIB, 24 out of 50 major cryptocurrencies on Pluang rose while 25 fell. Notable price changes include ONE at Rp41 with a 2.20% decline and COMP at Rp439.415 down 2.15%.

More News

Constellation Brands beats earnings and revenue estimates with strong beer and spirits sales.

Constellation Brands beats earnings and revenue estimates with strong beer and spirits sales.

Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...

Company Fundamentals
Bullish
27 minutes ago
Tilray Brands to report Q1 2027 results with expected revenue growth and ongoing losses

Tilray Brands to report Q1 2027 results with expected revenue growth and ongoing losses

Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...

Company Fundamentals
Neutral
31 minutes ago
Five stocks jump 21%-53% on news of acquisitions, blockchain, AI, and federal financing.

Five stocks jump 21%-53% on news of acquisitions, blockchain, AI, and federal financing.

On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...

Market News
Bullish
32 minutes ago
Five stocks drop sharply on Oct 6, led by ArriVent BioPharma after lung cancer drug trial failure.

Five stocks drop sharply on Oct 6, led by ArriVent BioPharma after lung cancer drug trial failure.

On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...

Market News
Bearish
32 minutes ago
Evercore raises Marvell's price target to $433 on strong AI and data center growth forecasts.

Evercore raises Marvell's price target to $433 on strong AI and data center growth forecasts.

Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...

Analyst Insights
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App